ClinicalTrials.Veeva

Menu

The Role of Bifidobacterium Animalis Ssp Lactis DR10 Supplementation in Women During Pregnancy and Lactation on Breast Milk IL-8 and Gut Mucosa Integrity in Infant

N

Naomi Esthernita

Status

Completed

Conditions

Bifidobacterium

Treatments

Other: Placebo
Dietary Supplement: Probiotic

Study type

Interventional

Funder types

Other

Identifiers

NCT02377544
FKUI-RSCM

Details and patient eligibility

About

Hopefully this research can help to provide the optimal nutrition management from pregnancy so that the babies wiil born with better quality of health and reduce the morbidity and mortality.

Until now, there is no data regarding probiotics in Indonesien breastmilk and the role of probiotics supplementation on pregnant women to the baby especially from inflammation pathways. The investigators hope the result of this research can help reducing infant morbidity and mortality rate in Indonesia, also has a benefit for future research.

Enrollment

70 patients

Sex

Female

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • pregnant women ,gestation age 32-34 weeks, normal pregnancy, plan to deliver spontaneously, no antibiotic
  • tend to give exclusive breastfeeding
  • want to join the research
  • well doing baby

Exclusion criteria

  • pregnant women with pre-eclampsia,bleeding,infection,premature rupture of the membrane or other chronic disease
  • plan to deliver by caesarean section

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Single Group Assignment

Masking

Quadruple Blind

70 participants in 2 patient groups, including a placebo group

Placebo
Placebo Comparator group
Description:
Saccharum lactis
Treatment:
Other: Placebo
Probiotic
Experimental group
Description:
Bifidobacterium animalis lactis
Treatment:
Dietary Supplement: Probiotic

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems